Inhibition of human carcinoma and neuroblastoma cell proliferation by anti-c-myc siRNA

Oligonucleotides

Volumn 16, Issue 1, 2006, Pages 15-25

  Kabilova, Tatyana O ^a   Chernolovskaya, Elena L ^a   Vladimirova, Albina V ^a   Vlassov, Valentin V ^a  

^a INSTITUTE OF CHEMICAL BIOLOGY AND FUNDAMENTAL MEDICINE   (Russian Federation)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; MYC PROTEIN; SMALL INTERFERING RNA;

ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CARCINOMA CELL; CELL DIVISION; CELL PROLIFERATION; CELL STRAIN KB 3 1; CELL STRAIN SK N MC; CONTROLLED STUDY; EXON; GENE EXPRESSION; GENE OVEREXPRESSION; GENE REPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; IN VITRO STUDY; NEUROBLASTOMA CELL; ONCOGENE C MYC; PRIORITY JOURNAL; PROTEIN EXPRESSION; RNA INTERFERENCE;

CARCINOMA; CELL LINE, TUMOR; CELL PROLIFERATION; GENE EXPRESSION; GENES, MYC; HUMANS; INTERFERON-ALPHA; NEUROBLASTOMA; PROTO-ONCOGENE PROTEINS C-MYC; RNA, MESSENGER; RNA, SMALL INTERFERING; TRANSFECTION;

EID: 33645834759     PISSN: 15454576     EISSN: None     Source Type: Journal    
DOI: 10.1089/oli.2006.16.15     Document Type: Article

References (39)

1. AMY, C.M., and BARTHOLOMEW, J.C. (1987). Regulation of N-myc transcript stability in human neuroblastoma and retinoblastoma cells. Cancer Res. 47, 6310-6314.
2. BAZAROV, A.V., ADACHI, S., LI, S.F., MATEYAK, M.K., WEI, S., and SEDIVY, J.M. (2001). A modest reduction in c-myc expression has minimal effects on cell growth and apoptosis but dramatically reduces susceptibility to ras and raf transformation. Cancer Res. 61, 1178-1186.
3. BERNASCONI, N.L., WORMHOUDT, T.A., and LAIRD-OFFRINGA, I.A. (2000). Posttranscriptional deregulation of myc genes in lung cancer cell lines. Am. J. Respir. Cell Mol. Biol. 23, 560-565.
4. CARMICHAEL, J., DeGRAFF, W.G., GAZDAR, A.F., MINNA, J.D., and MITCHELL, J.B. (1987). Evaluation of a tetrazolium-based semiautomated colorimetric assay: Assessment of chemosensitivity testing. Cancer Res. 47, 936-942.
5. CHATTOPADHYAY, N., KHER, R., and GODBOLE, M. (1993). Inexpensive SDS/phenol method for RNA extraction from tissues. Biotechniques 15, 24-26.
6. DANI, C., BLANCHARD, J.M., PIECHACZYK, M., EL SABOUTY, S., MARTY, L., and JEANTEUR, P. (1984). Extreme instability of myc mRNA in normal and transformed human cells. Proc. Natl. Acad. Sci. USA 81,7046-7050.
7. DEMETERCO, C., ITKIN-ANSARI, P., TYRBERG, B., FORD, L.P., JARVIS, R.A., and LEVINE F. (2002). c-Myc controls proliferation versus differentiation in human pancreatic endocrine cells. J. Clin. Endocrinol. Metab. 87, 3475-3485.
8. DIESBACH, P., N'KULI, F., DELMEE, M., and COURTOY, P. (2003). Infection by Mycoplasma hyorhinis strongly enhances uptake of antisense oligonucleotides: A reassessment of receptor-mediated endocytosis in the HepG2 cell line. Nucleic Acids Res. 31, 886-892.
9. ELBASHIR, S.M., HARBORTH, J., LENDECKEL, W., YALCIN, A., WEBER, K., and TUSCHL, T. (2001). Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 411, 494-498.
10. FAGOT, D., BUQUET-FAGOT, C., LALLEMAND, F., and MESTER, J. (1994). Antiproliferative effects of sodium butyrate in adriamycin-sensitive and -resistant human cancer cell lines. Anticancer Drugs 5, 548-556.
11. FEO, S., DI LIEGRO, C., JONES, T., READ, M., and FRIED, M. (1994). The DNA region around the c-myc gene and its amplification in human tumor cell lines. Oncogene 9, 955-961.
12. GALDERISI, U., BERNARDO, G., CIPOLLARO, M., PELUSO, G., CASCINO, A., COTRUFO, R., and MELONE, M.A. (1999). Differentiation and apoptosis of neuroblastoma cells: role of N-myc gene product. J. Cell. Biochem. 73, 97-105.
13. GAO, X., WANG, H., and SAIRENJI, T. (2004). Inhibition of Epstein-Barr virus (EBV) reactivation by short interfering RNAs targeting p38 mitogen-activated protein kinase or c-myc in EBV-positive epithelial cells. J. Virol. 78, 11798-11806.
14. GOSWAMI, P.C., ALBEE, L.D., SPITZ, D.R., and RIDNOUR, L.A. (1997). A polymerase chain reaction assay for simultaneous detection and quantitation of proto-oncogene and GAPD mRNAs in different cell growth rates. Cell Prolif. 30, 271-282.
15. GRAND, C.L., POWELL, T.J., NAGLE, R.B., BEARSS, D.J., TYE, D., GLEASON-GUZMAN, M., and HURLEY, L.H. (2004). Mutations in the G-quadriplex silencer element and their relationship to c-myc overexpression, NM23 repression, and therapeutic rescue. Proc. Natl Acad. Sci. USA 101, 6140-6145.
16. HANN, S.R., and EISENMAN, R.N. (1984). Proteins encoded by the human c-myc oncogene: Differential expression in neoplastic cells. Mol. Cell. Biol. 4, 2486-2497.
17. HEMMI, H., YAMADA, K., YOON, U., KATO, M., TANIGUCHI, F., TSUCHIDA, Y., and SHIMATAKE, H. (1995). Coexpression of the myc gene family members in human neuroblastoma cell lines. Biochem. Mol. Biol. Int. 36, 1135-1141.
18. HOHJOH, H. (2004). Enhancement of RNAi activity by improved siRNA duplexes. FEBS Lett. 557,193-198.
19. HOSONO, T., MIZUGUCHI, H., KATAYAMA, K., XU, Z., SAKURAI, F., ISHII-WATABE, A., KAWABATA, K., YAMAGUCHI, T., NAKAGAWA, S., MAYUMI, T., and HAYAKAWA, T. (2004). Adenovirus vector-mediated doxycycline-inducible RNA interference. Hum. Gene Ther. 15, 813-819.
20. JAIN, M., ARVANITIS, C., CHU, K., DEWEY, W., LEONHARDT, E., TRINH, M., SUNDBERG, C.D., BISHOP, J.M., and FELSHER, D.W. (2002). Sustained loss of a neoplastic phenotype by brief inactivation of Myc. Science 297, 102-104.
21. JUDGE, A.D., SOOD, V., SHOW, J.R., FANG, D., McCLINTOCK, K., and MacLACHLAN, I. (2005). Sequence-dependent stimulation of the mammalian innate immune response by synthetic siRNA. Nat. Biotechnol. 23, 457-462.
22. KABILOVA, T.O., CHERNOLOVSKAYA, E.L., VLADIMIROVA, A.V., and VLASSOV, V.V. (2004). Silencing of c-myc expression in tumor cells by siRNA. Nucleosides Nucleotides Nucleic Acids 23, 867-872.
23. LIPPMAN, S.M., GLISSON, B.S., KAVANAGH, J.J., LOTAN, R., HONG, W.K., PAREDES-ESPINOZA, M., HITTELMAN, W.N., HOLDENER, E.E., and KRAKOFF, I.H. (1993). Retinoic acid and interferon combination studies in human cancer. Eur. J. Cancer 5, 9-13.
24. MEISTER, G., and TUSCHL, T. (2004). Mechanisms of gene silencing by double-stranded RNA. Nature 431, 343-349.
25. MELLO, C.C., and CONTE, D. (2004). Revealing the world of RNA interference. Nature 431, 338-342.
26. NESBIT, C.E., TERSAK, J.M., and PROCHOWNIK, E.V. (1999). myc oncogenes and neoplastic disease. Oncogene 18, 3004-3016.
27. PASTURINO, F., STUART, D., PONZONI, M., and ALLEN, T.M. (2001). Targeted delivery of antisense oligonucleotides in cancer. J. Control. Release 74, 69-75.
28. PESSION, A., TONELLI, R., FRONZA, R., SCIAMANNA, E., CORRADINI, R., SFORZA, S., TEDESCHI, T., MARCHELLI, R., MONTANARO, L., CAMERIN, C., FRANZONI, M., and PAOLUCCI, G. (2004). Targeted inhibition of NMYC by peptide nucleic acid in N-myc amplified human neuroblastoma cells: Cell-cycle inhibition with induction of neuronal cell differentiation and apoptosis. Int. J. Oncol. 24, 265-272.
29. PROUDNIKOV, D., and MIRZABEKOV, A. (1996). Chemical methods of DNA and RNA fluorescent labeling. Nucleic Acids. Res. 24, 4535-4542.
30. RAMSAY, G., EVAN, G.I., and BISHOP, J.M. (1984). The protein encoded by the human proto-oncogene c-myc. Proc. Natl. Acad. Sci. USA 81, 7742-7746.
31. REYNOLDS, C.P., WANG, Y., MELTON, L.J., EINHORN, P.A., SLAMON, D.J., and MAURER, B.J. (2000). Retinoic acid-resistant neuroblastoma cell lines show altered Myc regulation and high sensitivity to fenretinide. Med. Pediatr. Oncol. 35, 597-602.
32. ROSENBLATT, M.N., BURNS, J.R., DUNCAN, V.E., and HUGHES, J.A. (2000). Infection of the macrophage cell line NR8383 with Mycobacterium tuberculosis (H37Ra) leads to an increase in oligodeoxynucleotide accumulation. Antisense Nucleic Acids Drug Dev. 10, 1-9.
33. SABICHI, A.L., and BIRRER, M.J. (1996). Regulation of nuclear oncogenes expressed in lung cancer cell lines. J. Cell. Biochem. 24 (Suppl), 218-227.
34. SIOUD, M. (2005). Induction of inflammatory cytokines and interferon responses by double-stranded and single-stranded siRNAs is sequence-dependent and requires endosomal localization. J. Mol. Biol. 348,1079-1090.
35. SHEN, L., ZHANG, C., AMBRUS, J.L., Jr., and WANG, J.H. (2005). Silencing of human c-myc oncogene expression by poly-DNP-RNA. Oligonucleotides 15, 23-35.
36. SPENCER, C.A., and GROUDINE, M. (1991). Control of c-myc regulation in normal and neoplastic cells. Adv. Cancer Res. 56, 1-48.
37. STEVENSON, M. (2004). Therapeutic potential of RNA interference. N. Engl. J. Med. 351, 1772-1777.
38. UI-TEI, K., NAITO, Y., TAKAHASHI, F., HARAGUCHI, T., OHKI-HAMAZAKI, H., JUNI, A., UEDA, R., and SAIGO, K. (2004). Guidelines for the selection of highly effective siRNA sequences for mammalian and chick RNA interference. Nucleic Acids Res. 32, 936-948.
39. WANG, Y., LIU, S., ZHANG, G., ZHOU, C., ZHU, H., ZHOU, X., QUAN, L., BAI, J., and XU, N. (2005). Knock-down of c-myc expression by RNAi inhibits MCF-7 breast tumor cells growth in vitro and in vivo. Breast Cancer Res. 7, R220-R228.